The differential effects of the radioprotectant drugs amifostine and sodium selenite treatment in combination with radiation therapy on constituent bone cells, Ewing's sarcoma of bone tumor cells, and rhabdomyosarcoma tumor cells in vitro

Journal of Orthopaedic Research

Volumn 26, Issue 11, 2008, Pages 1512-1519

  Margulies, Bryan S ^a   Damron, Timothy A ^a   Allen, Matthew J ^a  

^a State University of New York Upstate Medical University: College of Medicine   (United States)

Author keywords

Chondrocytes; Growth plate; Proliferation; Radiation therapy

Indexed keywords

ALKALINE PHOSPHATASE; AMIFOSTINE; CASPASE 3; OSTEOCALCIN; SODIUM SELENITE; RADIOPROTECTIVE AGENT;

ANIMAL CELL; ARTICLE; BONE CELL; BONE MARROW; BONE MINERALIZATION; BONE TUMOR; CANCER CELL; CANCER CELL CULTURE; CARTILAGE CELL; CELL ADHESION; CELL COUNT; CELL CULTURE; CELL FUNCTION; CELL PROTECTION; CELL SURVIVAL; CONTROLLED STUDY; CYTOTOXICITY; ENDOTHELIUM CELL; EWING SARCOMA; GAMMA RADIATION; HUMAN; HUMAN CELL; IN VITRO STUDY; MONOCYTE; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIATION PROTECTION; RADIOSENSITIVITY; RAT; RHABDOMYOSARCOMA; SENSITIVITY ANALYSIS; TUMOR CELL LINE; X RAY; ANIMAL; DRUG EFFECT; DRUG SCREENING; METABOLISM; NEOPLASM; RADIATION EXPOSURE; SOFT TISSUE TUMOR;

AMIFOSTINE; ANIMALS; BONE NEOPLASMS; CELL LINE, TUMOR; CELL SURVIVAL; DRUG SCREENING ASSAYS, ANTITUMOR; GAMMA RAYS; HUMANS; MICE; NEOPLASMS; OSTEOBLASTS; RADIATION-PROTECTIVE AGENTS; RATS; RHABDOMYOSARCOMA; SARCOMA, EWING'S; SODIUM SELENITE; SOFT TISSUE NEOPLASMS;

EID: 55449096698     PISSN: 07360266     EISSN: None     Source Type: Journal    
DOI: 10.1002/jor.20679     Document Type: Article

References (15)

1. Merchant TE, Kushner BH, Sheldon JM, et al. 1999. Effect of low-dose radiation therapy when combined with surgical resection for Ewing sarcoma. Med Pediatr Oncol 33:65-70.
2. Damron T, Margulies B, Strauss J, et al. 2003. Sequential histomorphometric changes following irradiation of the growth plate with and without radioprotectant. J Bone Joint Surg 85-A7:1302-1313.
3. Spadaro JA, Horton JA, Margulies BS, et al. 2005. Radioprotectant combinations spare radiation-induced damage to the physis more than fractionation alone. Int J Radiat Biol 1:759-765.
4. Margulies BS, Horton JA, Wang Y, et al. 2006. Effects of radiation therapy on chondrocytes in vitro. Calcif Tissue Int 78:302-313.
5. 3 integrins. J Cell Sci 105:1001-1012.
6. Spinella-Jaegle S, Roman-Roman S, Faucheu C, et al. 2001. Opposite effects of bone morphogenetic protein-2 and transforming growth factor-beta1 on osteoblast differentiation. Bone 29:323-330.
7. Gregory CA, Gunn WG, Peister A, et al. 2004. An alizarin red-based assay of mineralization by adherent cells in culture: comparison with cetylpyridinium chloride extraction. Anal Biochem 329:77-84.
8. Margulies B, Morgan H, Allen M, et al. 2003. Increased bone density following irradiation and the radioprotectant drug amifostine in a rat model. Am J Clin Oncol 26:e106-e114.
9. Scheven BA, Wassenaar AM, Kawilarang-de Haas EW, et al. 1987. Direct and indirect radiation effects on osteoclast formation in vitro. Bone Miner 2:291-300.
10. Khodarev NN, Kataoka Y, Murley JS, et al. 2004. Interaction of amifostine and ionizing radiation on transcriptional patterns of apoptotic genes expressed in human microvascular endothelial cells (HMEC). Int J Radiat Oncol Biol Phys 60:553-563.
11. Vaaraniemi J, Halleen JM, Kaarlonen K, et al. 2004. Intracellular machinery for matrix degradation in bone-resorbing osteoclasts. J Bone Miner Res 19:1432-1440.
12. Schneider LA, Dissemond J, Brenneisen P, et al. 2006. Adaptive cellular protection against UVA-1 induced lipid peroxidation in human dermal fibroblasts shows donor-to-donor variability and is glutathione dependent. Arch Dermatol Res 297:324-328.
13. Hopewell JW, Calvo W, Jaenke R, et al. 1993. Microvasculature and radiation damage. Recent Results Cancer Res 130:1-16.
14. Hofbauer KH, Gess B, Lohaus C, et al. 2003. Oxygen tension regulates the expression of a group of procollagen hydroxylases. Eur J Biochem 270:4515-4522.
15. Aviles A, Diaz-Maqueo JC, Talavera A. 1997. Bone marrow protection with amifostine in the treatment of high-risk malignant lymphoma. Eur J Cancer 33:1323-1325.